RxDoctor Payments Data

Katherine White, PA

Physician Assistant · Hattiesburg, MSNPI 1588280382

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 96.3% of the total across 195 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 18 manufacturers reported payments, led by AbbVie at 30.1% of the total. Reporting peaked in 2021 at $2,453 and has fallen 99.2% since, to $20 in 2025.

$4,878in general payments, 2019–2025

Across 195 payments — averaging $25.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Regeneron Healthcare Solutions, Inc.$553
  • Amgen$449
  • Lilly USA, LLC$403
  • Sanofi$395
  • LEO Pharma Inc.$245
  • plus $1K from 12 others

What the payments were for

  • Food & beverage$4,69896%
  • Education$1804%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,878 in reported general payments places this provider in the 85th percentile of 278 physician assistant providers in Mississippi.

See all physician assistant providers in Mississippi

Medicare billing

Part B allowed, 2024
$99,260
Medicare patients
410
Services billed
2,267

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab15$54,385
Fluorouracil33$1,527
Clobetasol Propionate39$1,524
Tacrolimus17$1,319
Triamcinolone Acetonide112$1,205
Calcipotriene11$1,142
Tretinoin22$1,062
Ketoconazole76$956
Azelaic Acid20$827
Metronidazole34$581
Fluocinonide23$545
Clindamycin Phosphate16$408
Nystatin26$285
Hydrocortisone21$268
Mupirocin37$252

Paid to pharmacies, not to this prescriber.

Other physician assistant in Hattiesburg

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →